top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Anticancer Drugs 2021
Anticancer Drugs 2021
Autore Meegan Mary J
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (594 p.)
Soggetto topico Research & information: general
Chemistry
Soggetto non controllato thymidylate synthase
cytotoxicity
1,2,3-triazole
1,3,4-oxadiazole
5-fluoruracil
pemetrexed
docking
3,4'-bis-guanidino
3-amino-4'-guanidino
diphenyl ether
phenyl pyridyl ether
intramolecular hydrogen bond
cancer cell viability
HL-60
BRAF
apoptosis
thieno[2,3-d][1,2,3]triazine
acetamide
H1299
HER2
EGFR
Bcl-2 inhibitors
Indole-based analogues
benzimidazole
MTT cytotoxic assay
cell cycle analysis
DNA fragmentation
ELISA
solid/lipid nanoparticles
phenstatin
letrozole
tubulin polymerisation inhibitor
aromatase inhibitor
breast cancer
hybrid molecule
dual-targeting molecule
designed multiple ligand
NaMSA
cyclophosphamide
histopathology
testis
urinary bladder
anticancer agents
enantioselective synthesis
gastric adenocarcinoma
tryptophanol
concentration-guided dosing
model informed dosing
physiologically based pharmacokinetics
sorafenib
tyrosil-DNA-phosphodiesterase 1
adamantane
resin acid
TDP1
cytotoxic agents
apoptosis induction
HT-29 cells
MDA-MB-231 cells
mechanism prediction
STAT inhibitors
miR-21
hydrazide derivatives
nitrogen scaffolds
mitoxantrone
cardiotoxicity
inflammation
oxidative stress
age
cumulative dose
Trk
NTRK
tissue-agnostic
larotrectinib
entrectinib
Trk fusion
protein kinase inhibitors
USFDA
cancer
patent review
generic product
doxazosin
MD simulations
combretastatin A-4
cytotoxic activity
hybrid compounds
indazole
mucin
MUC1
MUC16
immunotherapy
cancer vaccine
CAR (chimeric antigen receptor)
ADC (antibody-drug conjugate)
thiourea
interleukin-6
trypan blue assay
chalcones
exportin-1
covalent binding
CovDock
anticancer activity
xanthone
in vitro
in vivo
isolation
synthesis
heterocyclic compound
benzenesulfonamides
imidazoles
alkylated
colony formation
tumor spheroids
HDAC inhibitors
chalcone
dual inhibitors
carvedilol
kidney
toxicity
7-deaza-4'-thioadenosine derivatives
multi-kinase inhibitor
anticancer
nucleoside
Imiquimod
drug efflux
multidrug resistance
Toll-Like Receptor
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910576874303321
Meegan Mary J  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Creatine Supplementation for Health and Clinical Diseases
Creatine Supplementation for Health and Clinical Diseases
Autore Kreider Richard B
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (562 p.)
Soggetto topico Research & information: general
Biology, life sciences
Food & society
Soggetto non controllato ergogenic aids
cellular metabolism
phosphagens
sarcopenia
cognition
diabetes
creatine synthesis deficiencies
concussion
traumatic brain injury
spinal cord injury
muscle atrophy
rehabilitation
pregnancy
immunity
anti-inflammatory
antioxidant
anticancer
creatine
nutritional supplements
fertility
newborn
development
brain injury
post-viral fatigue syndrome
chronic fatigue syndrome
GAA
creatine kinase
dietary supplements
exercise
skeletal muscle
glycemic control
type 2 diabetes mellitus
phosphorylcreatine
dietary supplement
ergogenic aid
youth
athletes
osteoporosis
osteosarcopenia
frailty
cachexia
innate immunity
adaptive immunity
inflammation
macrophage polarization
cytotoxic T cells
toll-like receptors
vascular pathology
cardiovascular disease
oxidative stress
vascular health
female
menstrual cycle
hormones
exercise performance
menopause
mood
children
height
BMI-for-age
stature-for-age
growth
phosphocreatine
creatine transporter
supplementation
treatment
heart
heart failure
ischemia
myocardial infarction
anthracycline
cardiac toxicity
energy metabolism
cell survival
bioinformatics
systems biology
cellular allostasis
dynamic biosensor
pleiotropic effects of creatine (Cr) supplementation
inflammatory bowel diseases (IBD)
ulcerative colitis
Crohn’s disease
creatine kinase (CK)
phosphocreatine (PCr)
creatine transporter (CrT)
intestinal epithelial cell protection
intestinal tissue protection
creatine perfusion
organ transplantation
Adenosine mono-phosphate (AMP)
activated protein kinase (AMPK)
liver kinase B1 (LKB1)
mitochondrial permeability transition pore (mPTP)
reactive oxygen species (ROS)
glucose transporter (GLUT)
T cell antitumor immunity
metabolic regulator
cancer immunotherapy
supplements
muscle damage
recovery
immobilization
atrophy
muscular dystrophy
amyotrophic lateral sclerosis
Parkinson’s Disease
cardiopulmonary disease
mitochondrial cytopathy
hypertrophy
athletic performance
weightlifting
resistance exercise
training
muscular power
muscular adaptation
muscle fatigue
adipose tissue
muscle strength
physiological adaptation
mitochondria
thermogenesis
MAP kinase signaling system
sodium-chloride-dependent neurotransmitter symporters
signal transduction
intradialytic creatine supplementation
hemodialysis
muscle
protein energy wasting
clinical trial
muscle weakness
chronic fatigue
cognitive impairment
depression
anemia
resistance training
sports nutrition
strength
toxicity
methylation
hyperhomocysteinemia
neuromodulation
MCDA
mitochondriopathia
cardiac infarction
long COVID
hypoxia
stroke
neurodegenerative diseases
noncommunicable disease
adenosine 5′-monopnophosphate-activated protein kinase
anthracyclines
creatine supplementation
cardiac signaling
cardiotoxicity
doxorubicin
soy
vegetarian/vegan diet
amino acids
dietary ingredients
performance
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910566476003321
Kreider Richard B  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Emerging Challenges of Cardiovascular and Metabolic Dysfunctions in Cardio-oncology: From Bench to Bedside
Emerging Challenges of Cardiovascular and Metabolic Dysfunctions in Cardio-oncology: From Bench to Bedside
Autore Nebigil Canan G
Pubbl/distr/stampa Frontiers Media SA, 2020
Descrizione fisica 1 electronic resource (127 p.)
Soggetto topico Medicine
Soggetto non controllato cardiooncology
cardiotoxicity
antracyclines
biomarkers
GPCR (G protein coupled receptors)
epigenetics (methylation/demethylation)
HPSC-cardiomyocytes
HDLP
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Emerging Challenges of Cardiovascular and Metabolic Dysfunctions in Cardio-oncology
Record Nr. UNINA-9910557230403321
Nebigil Canan G  
Frontiers Media SA, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Immunotherapy, Tumor Microenvironment and Survival Signaling
Immunotherapy, Tumor Microenvironment and Survival Signaling
Autore Golubovskaya Vita
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (376 p.)
Soggetto topico Medicine
Clinical & internal medicine
Soggetto non controllato Autophagy
colorectal cancer
immunotherapy
tumor stroma
tumor microenvironment
immune checkpoint inhibitors
chemotherapy
tyrosine kinase inhibitors
angiogenesis
check point inhibitors
programmed cell death protein 1
programmed cell death 1 ligand 1
cardiotoxicity
lung metastasis
CAR-T
hypoxia
tumor
microenvironment
CD19
BCMA
cancer
melanoma
immune escape
antigen loss
chimeric antigen receptor
electroporation
lentivirus
lentiviral transduction
macrophages
leukemia cells
lytic peptides
targeted therapy
dendritic cells
pathogenesis
risk factors
breast cancer
resistance
checkpoint
targeted treatment
personalized medicine
pediatric solid tumors
chimeric antigen receptors
cancer vaccines
oncolytic viral therapy
immunomodulation
DCLK1
tumor stem cells
clonogenicity
mitochondria
mitochondrial transfer
tunneling nanotubes
triple-negative breast cancer
immune checkpoint inhibitor
combination therapy
cancer nanomedicine
tumor antigens
cancer metabolism
cancer immunotherapy
nanoparticles
immunotherapeutic agent
immunomodulators
tuft cells
cancer stem cells
immunotherapies
myeloid-derived suppressor cells
regulatory T cells
crosstalk
tumor immune evasion
cell-cell contact
β2 integrins
CD18
CD11
CAR-T cells
CD37
cell therapy
tumor antigen
lymphoma
CAR macrophage
CAR T cell
solid tumors
immunometabolism
miRNA
immunogenic cell death
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910580205403321
Golubovskaya Vita  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Ischemic Heart Disease in the Context of Different Comorbidities
Ischemic Heart Disease in the Context of Different Comorbidities
Autore Costache Irina-Iuliana
Pubbl/distr/stampa Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Descrizione fisica 1 electronic resource (242 p.)
Soggetto topico Medicine
Cardiovascular medicine
Soggetto non controllato coronary artery disease
ischemic heart disease
atherosclerosis
genetic risk factors
heritability
polymorphism
GWAS
PRS
COVID-19
myocardial ischemia
electrocardiography
accelerated atherosclerosis
coronary spasm
coronary thrombosis
endothelial dysfunction
cancer
prevention
radiotherapy
chemotherapy
liver cirrhosis
prevalence
liver transplantation
treatment
myocardial injury
cytokines
biomarkers
heart failure
left ventricular remodeling
myocardial infarction
wall stress
inflammation
neurohormonal activation
inflammatory bowel disease
ulcerative colitis
Crohn's disease
cardiovascular risk
frailty
chronic coronary syndrome
elderly
acute coronary syndrome
carbon monoxide poisoning
severity of poisoning
cardiotoxicity
troponin
cardiac dysfunction
non-alcoholic fatty liver disease
liver-heart axis
ISBN 3-0365-5809-8
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910637784603321
Costache Irina-Iuliana  
Basel, : MDPI - Multidisciplinary Digital Publishing Institute, 2022
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
New Prognostic and Predictive Markers in Cancer Progression
New Prognostic and Predictive Markers in Cancer Progression
Autore Costantini Susan
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (294 p.)
Soggetto topico Medicine
Soggetto non controllato MSI2
OSCC
oral cancer
musashi 2
prognosis
N-cadherin
EMT
breast cancer
new metastasis
eribulin
blood
biomarker
bladder cancer
immune checkpoint inhibitor
CD8+ T effector cells
microRNA
biomarkers
head and neck cancer
laryngeal cancer
prediction
metastasis
lifestyle habit
chemo-/radio resistance
therapeutic target
AKT
AR
castration-resistant prostate cancer (CRPC)
MAPK
mTOR
PI3K
prostate cancer
therapeutic resistance
WNT
miRNA
melanoma
melanoma resistance to MAPK/MEK inhibitors
resistance to immune checkpoint inhibitors
TNBC
BRCA1/2
HRR
PDL1
TILs
PI3KCA
PTEN
CTCs
CSC
pancreatic cancer
K-RAS oncogene
oncogene dependency
targeted therapies
genomic mutations
transcriptomics
metabolomics
selenoproteins
cancer
HUB nodes
major histocompatibility complex (MHC)
human leukocyte antigen (HLA)
antigen processing machinery (APM) molecules
carcinogenesis
tumor predisposition
cancer immunotherapy
pheochromocytoma
paraganglioma
head and neck neoplasms
head and neck tumors
genetic syndromes
mutations
hyperglycemia
cardioncology
nivolumab
cytokines
cardiotoxicity
acetyltransferase
cancer prognosis
NAA10
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557794803321
Costantini Susan  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Physiological and Pathological Role of ROS: Benefits and Limitations of Antioxidant Treatment
Physiological and Pathological Role of ROS: Benefits and Limitations of Antioxidant Treatment
Autore Di Meo Sergio
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Descrizione fisica 1 electronic resource (236 p.)
Soggetto topico Research & information: general
Biology, life sciences
Soggetto non controllato CTCL
apoptosis
cell viability
c-FLIP
XIAP
artemisinin
SH-SY5Y cells
hippocampal neurons
H2O2
AMPK pathway
atherosclerosis
sphingomyelin synthase 2
endothelial dysfunction
endoplasmic reticulum stress
β-catenin
insulin resistance
cancer
cardiovascular disease
neurodegenerative disorders
exercise
mitochondria
oxidative stress
PGC-1
Nrf2
UCPs
ROS
light
DNA damage
evolution
D-box
cavefish
Spalax
trimethylamine N-oxide
cardiomyocytes
cardiotoxicity
mitochondrial membrane potential
CORM-2
NADPH oxidase
AP-1
HO-1
Renal cell carcinoma (RCC)
reactive oxygen species (ROS)
glutathione (GSH) metabolism
cancer therapy
clear cell RCC
papillary RCC
chromophobe RCC
sarcopenia
reactive oxygen species
redox signaling
antioxidant supplementation
protein aggregation
redox
proteinopathy
peroxiredoxins
tumorigenesis
ROS scavengers
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Physiological and Pathological Role of ROS
Record Nr. UNINA-9910557430503321
Di Meo Sergio  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui